Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero

Frontiers in Behavioral Neuroscience

Volumn 8, Issue November, 2014, Pages 1-13

  Banerjee, Anwesha ^a   Engineer, Crystal T ^a   Sauls, Bethany L ^a   Morales, Anna A ^a   Kilgard, Michael P ^a   Ploski, Jonathan E ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Amygdala; Autism; Emotion; Learning; Memory; Pavlovian fear conditioning; Valproic acid

Indexed keywords

VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; AUDITORY RESPONSE; AUDITORY THRESHOLD; AUTISM; COMPULSION; CONDITIONING; CONTROLLED STUDY; DISEASE ASSOCIATION; EMOTIONAL LEARNING; EMOTIONAL LEARNING IMPAIRMENT; EMOTIONAL STRESS; FEAR; FOOTSHOCK; HYPOACTIVITY; LEARNING; LEARNING DISORDER; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; NEWBORN; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OPEN FIELD TEST; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PROGENY; RAT; REINFORCEMENT; SOCIAL DISABILITY; SOCIAL INTERACTION; SURVIVAL RATE;

EID: 84927524054     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.0038     Document Type: Article

References (74)

1. Adachi, M., Autry, A. E., Covington, H. E. 3rd., and Monteggia, L. M. (2009). MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J. Neurosci. 29, 4218-4227. doi: 10.1523/JNEUROSCI.4225-08.2009.
2. Amir, R. E., Van Den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188. doi: 10.1038/13810.
3. Arndt, T. L., Stodgell, C. J., and Rodier, P. M. (2005). The teratology of autism. Int. J. Dev. Neurosci. 23, 189-199. doi: 10.1016/j.ijdevneu.2004.11.001.
4. Bachevalier, J., and Loveland, K. A. (2006). The orbitofrontal-amygdala circuit and self-regulation of social-emotional behavior in autism. Neurosci. Biobehav. Rev. 30, 97-117. doi: 10.1016/j.neubiorev.2005.07.002.
5. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., et al. (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63-77. doi: 10.1017/S0033291700028099.
6. Bambini-Junior, V., Rodrigues, L., Behr, G. A., Moreira, J. C., Riesgo, R., and Gottfried, C. (2011). Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res. 1408, 8-16. doi: 10.1016/j.brainres.2011.06.015.
7. Bernier, R., Dawson, G., Panagiotides, H., and Webb, S. (2005). Individuals with autism spectrum disorder show normal responses to a fear potential startle paradigm. J. Autism Dev. Disord. 35, 575-583. doi: 10.1007/s10803-005-0002-0.
8. Binkerd, P. E., Rowland, J. M., Nau, H., and Hendrickx, A. G. (1988). Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam. Appl. Toxicol. 11, 485-493. doi: 10.1016/0272-0590(88)90112-1.
9. Centanni, T. M., Booker, A. B., Sloan, A. M., Chen, F., Maher, B. J., Carraway, R. S., et al. (2014). Knockdown of the dyslexia-associated gene Kiaa0319 impairs temporal responses to speech stimuli in rat primary auditory cortex. Cereb. Cortex 24, 1753-1766. doi: 10.1093/cercor/bht028.
10. Charman, T., Pickles, A., Simonoff, E., Chandler, S., Loucas, T., and Baird, G. (2011). IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP). Psychol. Med. 41, 619-627. doi: 10.1017/S0033291710000991.
11. Chevallier, C., Kohls, G., Troiani, V., Brodkin, E. S., and Schultz, R. T. (2012). The social motivation theory of autism. Trends Cogn. Sci. 16, 231-239. doi: 10.1016/j.tics.2012.02.007.
12. Chomiak, T., Hung, J., Cihal, A., Dhaliwal, J., Baghdadwala, M. I., Dzwonek, A., et al. (2014). Auditory-cued sensorimotor task reveals disengagement deficits in rats exposed to the autism-associated teratogen valproic acid. Neuroscience 268, 212-220. doi: 10.1016/j.neuroscience.2014.02.049.
13. Christianson, A. L., Chesler, N., and Kromberg, J. G. (1994). Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child Neurol. 36, 361-369. doi: 10.1111/j.1469-8749.1994.tb11858.x.
14. Cohen, O. S., Varlinskaya, E. I., Wilson, C. A., Glatt, S. J., and Mooney, S. M. (2013). Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. Int. J. Dev. Neurosci. 31, 740-750. doi: 10.1016/j.ijdevneu.2013.09.002.
15. Downing, C., Biers, J., Larson, C., Kimball, A., Wright, H., Ishii, T., et al. (2010). Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice. Toxicol. Sci. 116, 632-639. doi: 10.1093/toxsci/kfq140.
16. Edalatmanesh, M. A., Nikfarjam, H., Vafaee, F., and Moghadas, M. (2013). Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism. Brain Res. 1526, 15-25. doi: 10.1016/j.brainres.2013.06.024.
17. Engineer, C. T., Centanni, T. M., Im, K. W., Borland, M. S., Moreno, N. A., Carraway, R. S., et al. (2014a). Degraded auditory processing in a rat model of autism limits the speech representation in non-primary auditory cortex. Dev. Neurobiol. 74, 972-986. doi: 10.1002/dneu.22175.
18. Engineer, C. T., Centanni, T. M., Im, K. W., Rahebi, K. C., Buell, E. P., and Kilgard, M. P. (2014b). Degraded speech sound processing in a rat model of fragile X syndrome. Brain Res. 1564, 72-84. doi: 10.1016/j.brainres.2014.03.049.
19. Evans, D. W., Canavera, K., Kleinpeter, F. L., Maccubbin, E., and Taga, K. (2005). The fears, phobias and anxieties of children with autism spectrum disorders and Down syndrome: comparisons with developmentally and chronologically age matched children. Child Psychiatry Hum. Dev. 36, 3-26. doi: 10.1007/s10578-004-3619-x.
20. Eyal, S., Yagen, B., Sobol, E., Altschuler, Y., Shmuel, M., and Bialer, M. (2004). The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45, 737-744. doi: 10.1111/j.0013-9580.2004.00104.x.
21. Favre, M. R., Barkat, T. R., Lamendola, D., Khazen, G., Markram, H., and Markram, K. (2013). General developmental health in the VPA-rat model of autism. Front. Behav. Neurosci. 7:88. doi: 10.3389/fnbeh.2013.00088.
22. Fernandez, S. M., Lewis, M. C., Pechenino, A. S., Harburger, L. L., Orr, P. T., Gresack, J. E., et al. (2008). Estradiol-induced enhancement of object memory consolidation involves hippocampal extracellular signal-regulated kinase activation and membrane-bound estrogen receptors. J. Neurosci. 28, 8660-8667. doi: 10.1523/JNEUROSCI.1968-08.2008.
23. Frick, K. M., and Gresack, J. E. (2003). Sex differences in the behavioral response to spatial and object novelty in adult C57BL/6 mice. Behav. Neurosci. 117, 1283-1291. doi: 10.1037/0735-7044.117.6.1283.
24. Frisch, C., Husch, K., Angenstein, F., Kudin, A., Kunz, W., Elger, C. E., et al. (2009). Dose-dependent memory effects and cerebral volume changes after in utero exposure to valproate in the rat. Epilepsia 50, 1432-1441. doi: 10.1111/j.1528-1167.2008.01943.x.
25. Gaigg, S. B., and Bowler, D. M. (2007). Differential fear conditioning in Asperger's syndrome: implications for an amygdala theory of autism. Neuropsychologia 45, 2125-2134. doi: 10.1016/j.neuropsychologia.2007.01.012.
26. Golden, S. A., Covington, H. E. 3rd., Berton, O., and Russo, S. J. (2011). A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183-1191. doi: 10.1038/nprot.2011.361.
27. Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., and Manji, H. K. (2004). Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol. Psychiatry 9, 734-755. doi: 10.1038/sj.mp.4001518.
28. Green, M. R., Barnes, B., and Mccormick, C. M. (2013a). Social instability stress in adolescence increases anxiety and reduces social interactions in adulthood in male Long-Evans rats. Dev. Psychobiol. 55, 849-859. doi: 10.1002/dev.21077.
29. Green, S. A., Rudie, J. D., Colich, N. L., Wood, J. J., Shirinyan, D., Hernandez, L., et al. (2013b). Overreactive brain responses to sensory stimuli in youth with autism spectrum disorders. J. Am. Acad. Child Adolesc. Psychiatry 52, 1158-1172. doi: 10.1016/j.jaac.2013.08.004.
30. Haberland, M., Montgomery, R. L., and Olson, E. N. (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42. doi: 10.1038/nrg2485.
31. Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., et al. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68, 1095-1102. doi: 10.1001/archgenpsychiatry.2011.76.
32. Ingram, J. L., Peckham, S. M., Tisdale, B., and Rodier, P. M. (2000). Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22, 319-324. doi: 10.1016/S0892-0362(99)00083-5.
33. Jergil, M., Kultima, K., Gustafson, A. L., Dencker, L., and Stigson, M. (2009). Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. Toxicol. Sci. 108, 132-148. doi: 10.1093/toxsci/kfp002.
34. Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., and Matsuda, T. (2013). Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol. 16, 91-103. doi: 10.1017/S1461145711001714.
35. Kemper, T. L., and Bauman, M. (1998). Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 57, 645-652. doi: 10.1097/00005072-199807000-00001.
36. Kerr, D. M., Downey, L., Conboy, M., Finn, D. P., and Roche, M. (2013). Alterations in the endocannabinoid system in the rat valproic acid model of autism. Behav. Brain Res. 249, 124-132. doi: 10.1016/j.bbr.2013.04.043.
37. Kilgard, M. P., and Merzenich, M. M. (1999). Distributed representation of spectral and temporal information in rat primary auditory cortex. Hear. Res. 134, 16-28. doi: 10.1016/S0378-5955(99)00061-1.
38. Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Yang, S. I., Cheong, J. H., et al. (2011). The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett. 201, 137-142. doi: 10.1016/j.toxlet.2010.12.018.
39. Kultima, K., Jergil, M., Salter, H., Gustafson, A. L., Dencker, L., and Stigson, M. (2010). Early transcriptional responses in mouse embryos as a basis for selection of molecular markers predictive of valproic acid teratogenicity. Reprod. Toxicol. 30, 457-468. doi: 10.1016/j.reprotox.2010.05.014.
40. Kwan, P., Sills, G. J., and Brodie, M. J. (2001). The mechanisms of action of commonly used antiepileptic drugs. Pharmacol. Ther. 90, 21-34. doi: 10.1016/S0163-7258(01)00122-X.
41. Lazic, S. E., and Essioux, L. (2013). Improving basic and translational science by accounting for litter-to-litter variation in animal models. BMC Neurosci. 14:37. doi: 10.1186/1471-2202-14-37.
42. Lin, H. C., Gean, P. W., Wang, C. C., Chan, Y. H., and Chen, P. S. (2013). The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PLoS ONE 8:e55248. doi: 10.1371/journal.pone.0055248.
43. Mao, R., Page, D. T., Merzlyak, I., Kim, C., Tecott, L. H., Janak, P. H., et al. (2009). Reduced conditioned fear response in mice that lack Dlx1 and show subtype-specific loss of interneurons. J. Neurodev. Disord. 1, 224-236. doi: 10.1007/s11689-009-9025-8.
44. Markram, K., Rinaldi, T., La Mendola, D., Sandi, C., and Markram, H. (2008). Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33, 901-912. doi: 10.1038/sj.npp.1301453.
45. Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., et al. (2008). Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477-488. doi: 10.1016/j.ajhg.2007.12.009.
46. Martin, H. G., and Manzoni, O. J. (2014). Late onset deficits in synaptic plasticity in the valproic acid rat model of autism. Front. Cell. Neurosci. 8:23. doi: 10.3389/fncel.2014.00023.
47. Miller, J. N., and Ozonoff, S. (2000). The external validity of Asperger disorder: lack of evidence from the domain of neuropsychology. J. Abnorm. Psychol. 109, 227-238. doi: 10.1037/0021-843X.109.2.227.
48. Moldrich, R. X., Leanage, G., She, D., Dolan-Evans, E., Nelson, M., Reza, N., et al. (2013). Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav. Brain Res. 257, 253-264. doi: 10.1016/j.bbr.2013.09.049.
49. Montgomery, R. L., Hsieh, J., Barbosa, A. C., Richardson, J. A., and Olson, E. N. (2009). Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc. Natl. Acad. Sci. U.S.A. 106, 7876-7881. doi: 10.1073/pnas.0902750106.
50. Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., et al. (2000). A clinical study of 57 children with fetal anticonvulsant syndromes. J. Med. Genet. 37, 489-497. doi: 10.1136/jmg.37.7.489.
51. Munson, J., Dawson, G., Sterling, L., Beauchaine, T., Zhou, A., Elizabeth, K., et al. (2008). Evidence for latent classes of IQ in young children with autism spectrum disorder. Am. J. Ment. Retard. 113, 439-452. doi: 10.1352/2008.113:439-452.
52. Ogawa, T., Kuwagata, M., Hori, Y., and Shioda, S. (2007). Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy. Toxicol. Lett. 174, 18-24. doi: 10.1016/j.toxlet.2007.08.006.
53. Oguchi-Katayama, A., Monma, A., Sekino, Y., Moriguchi, T., and Sato, K. (2013). Comparative gene expression analysis of the amygdala in autistic rat models produced by pre-and post-natal exposures to valproic acid. J. Toxicol. Sci. 38, 391-402. doi: 10.2131/jts.38.391.
54. Perez, C. A., Engineer, C. T., Jakkamsetti, V., Carraway, R. S., Perry, M. S., and Kilgard, M. P. (2013). Different timescales for the neural coding of consonant and vowel sounds. Cereb. Cortex 23, 670-683. doi: 10.1093/cercor/bhs045.
55. Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., and Klein, P. S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741. doi: 10.1074/jbc.M101287200.
56. Polley, D. B., Read, H. L., Storace, D. A., and Merzenich, M. M. (2007). Multiparametric auditory receptive field organization across five cortical fields in the albino rat. J. Neurophysiol. 97, 3621-3638. doi: 10.1152/jn.01298.2006.
57. Rasalam, A. D., Hailey, H., Williams, J. H., Moore, S. J., Turnpenny, P. D., Lloyd, D. J., et al. (2005). Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev. Med. Child Neurol. 47, 551-555. doi: 10.1017/S0012162205001076.
58. Rodier, P. M., Ingram, J. L., Tisdale, B., and Croog, V. J. (1997). Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 11, 417-422. doi: 10.1016/S0890-6238(97)80001-U.
59. Rodier, P. M., Ingram, J. L., Tisdale, B., Nelson, S., and Romano, J. (1996). Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370, 247-261.
60. Schneider, T., and Przewlocki, R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30, 80-89. doi: 10.1038/sj.npp.1300518.
61. Schneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., et al. (2008). Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33, 728-740. doi: 10.1016/j.psyneuen.2008.02.011.
62. Schneider, T., Ziolkowska, B., Gieryk, A., Tyminska, A., and Przewlocki, R. (2007). Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl) 193, 547-555. doi: 10.1007/s00213-007-0795-y.
63. Schultz, R. T. (2005). Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int. J. Dev. Neurosci. 23, 125-141. doi: 10.1016/j.ijdevneu.2004.12.012.
64. Shaked, M., Weissmuller, K., Svoboda, H., Hortschansky, P., Nishino, N., Wolfl, S., et al. (2008). Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. PLoS ONE 3:e2668. doi: 10.1371/journal.pone.0002668.
65. South, M., Larson, M. J., White, S. E., Dana, J., and Crowley, M. J. (2011). Better fear conditioning is associated with reduced symptom severity in autism spectrum disorders. Autism Res. 4, 412-421. doi: 10.1002/aur.221.
66. South, M., Newton, T., and Chamberlain, P. D. (2012). Delayed reversal learning and association with repetitive behavior in autism spectrum disorders. Autism Res. 5, 398-406. doi: 10.1002/aur.1255.
67. Sui, L., and Chen, M. (2012). Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories. Brain Res. Bull. 87, 556-563. doi: 10.1016/j.brainresbull.2012.01.011.
68. Umeda, T., Takashima, N., Nakagawa, R., Maekawa, M., Ikegami, S., Yoshikawa, T., et al. (2010). Evaluation of Pax6 mutant rat as a model for autism. PLoS ONE 5:e15500. doi: 10.1371/journal.pone.0015500.
69. Vajda, F. J., O'brien, T. J., Hitchcock, A., Graham, J., Cook, M., Lander, C., et al. (2004). Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J. Clin. Neurosci. 11, 854-858. doi: 10.1016/j.jocn.2004.05.003.
70. Vorhees, C. V. (1987). Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats. Psychopharmacology (Berl) 92, 173-179. doi: 10.1007/BF00177911.
71. Wang, C. C., Lin, H. C., Chan, Y. H., Gean, P. W., Yang, Y. K., and Chen, P. S. (2013). 5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model. Int. J. Neuropsychopharmacol. 16, 2027-2039. doi: 10.1017/S1461145713000473.
72. Weisbrot, D. M., Gadow, K. D., Devincent, C. J., and Pomeroy, J. (2005). The presentation of anxiety in children with pervasive developmental disorders. J. Child Adolesc. Psychopharmacol. 15, 477-496. doi: 10.1089/cap.2005.15.477.
73. Wolff, J. J., and Symons, F. J. (2013). An evaluation of multi-component exposure treatment of needle phobia in an adult with autism and intellectual disability. J. Appl. Res. Intellect. Disabil. 26, 344-348. doi: 10.1111/jar.12002.
74. Zhao, M. G., Toyoda, H., Ko, S. W., Ding, H. K., Wu, L. J., and Zhuo, M. (2005). Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J. Neurosci. 25, 7385-7392. doi: 10.1523/JNEUROSCI.1520-05.2005.